Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
Eligibility Criteria
- 1. Self-reported type 1 diabetes
- 2. Prescribed, obtained, and have been using the Omnipod 5 System for no more than two weeks or plan to start using the system within the next two weeks
- 3. Willing to use only the following types of U-100 insulin during the study: Humalog U-100, Novolog, or Admelog
- 4. Able to read and speak English or Spanish (when available) fluently and reside full time in the United States
- 5. Willing to collect A1C samples using a provided home kit and send the samples to the registry specific core laboratory at baseline and 3, 6, 9 and 12 months
- 6. Willing and able to complete registry assessments every two weeks
- 7. Willing and able to complete registry outcome questionnaires at baseline, 6 months and end of study (or at withdrawal)
- 8. Is not currently pregnant or planning to become pregnant in the next 12 months and is using a reliable form of birth control
- 9. Access to internet via phone, tablet and/or computer to use the registry online platform
- 10. Willing to provide CGM and insulin delivery data collected prior to using the Omnipod 5 System, if available (participants will not be excluded if data is not provided)
- 11. Willing and able to provide informed consent (or assent) and/or has a parent/guardian willing and able to provide informed consent as applicable
- 1. Diagnosed with sickle cell anemia and/or hemoglobinopathy
- 2. Planned blood transfusions over the course of the study or has received a blood transfusion within 3 months prior to starting on Omnipod 5
- 3. Adults that are unable to provide informed consent
Ages Eligible for Study
2 Years to
Sexes Eligible for Study
ALL
Accepts Healthy Volunteers
No